---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000716"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2023-01-12T23:59:59+00:00"
generated_at: "2026-06-20T16:03:46.925962+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics extends HQ lease by one year at $24,885/month

## Summary
- Lease amendment extends headquarters lease from Jan 31, 2023 to Jan 31, 2024.
- Monthly rent set at $24,885 for the extended term; plus utilities and maintenance.
- Fulgent Therapeutics LLC (subsidiary) amended lease with landlord E&E Plaza LLC.

## SEC filing metadata
- accession: 0000950170-23-000716
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2023-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017023000716/0000950170-23-000716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017023000716/flgt-20230106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000716
- JSON: https://secwatch.observer/filing/0000950170-23-000716.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000716.txt

## Key facts
- Material Agreements
  Fulgent Genetics, Inc. amended Lease Amendment (effective 2023-01-06).
  - Action: amendment
  - Agreement: lease
  - Effective: 2023-01-06
  source text: On January 6, 2023, Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. (the “Company”), amended its existing office lease agreement for the Company’s headquarters at 4978 Santa Anita Avenue, Temple City, California 91780 (the “Lease Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017023000716/0000950170-23-000716-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.